Tetsuhiro Kajikawa1, Fatimah Meshikhes2, Tomoki Maekawa1, Evlambia Hajishengallis3, Kavita B Hosur1, Toshiharu Abe1, Kevin Moss4, Triantafyllos Chavakis5, George Hajishengallis1. 1. Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA. 2. Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA. 3. Department of Preventive and Restorative Sciences, Division of Pediatric Dentistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA. 4. Department of Dental Ecology, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 5. Institute for Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.
Abstract
AIM: We have previously shown that the secreted glycoprotein milk fat globule epidermal growth factor 8 (MFG-E8) has anti-inflammatory and anti-osteoclastogenic properties. Our objective was to investigate the potential of MFG-E8 as a diagnostic or therapeutic agent in periodontitis. MATERIALS AND METHODS: Periodontitis was induced in non-human primates (NHPs) by placing ligatures around posterior teeth on both halves of the mandible for a split-mouth design: one side was treated with MFG-E8-Fc and the other with Fc control. Disease was assessed by clinical periodontal examinations, radiographic analysis of bone loss, and analysis of cytokine mRNA expression in gingival biopsy samples. Gingival crevicular fluid (GCF) was collected from human healthy volunteers or subjects with gingivitis, chronic moderate periodontitis, or chronic severe periodontitis. Additionally, GCF was collected from a subset of severe periodontitis patients following scaling and root planing (SRP) and after pocket reduction surgery. GCF was analysed to quantify MFG-E8 and periodontitis-relevant cytokines using multiplex assays. RESULTS: In NHPs, sites treated with MFG-E8-Fc exhibited significantly less ligature-induced periodontal inflammation and bone loss than Fc control-treated sites. In humans, the GCF levels of MFG-E8 were significantly higher in health than in periodontitis, whereas the reverse was true for the proinflammatory cytokines tested. Consistently, MFG-E8 was elevated in GCF after both non-surgical (SRP) and surgical periodontal treatment of periodontitis patients. CONCLUSION: MFG-E8 is, in principle, a novel therapeutic agent and biomarker of periodontitis.
AIM: We have previously shown that the secreted glycoprotein milk fat globule epidermal growth factor 8 (MFG-E8) has anti-inflammatory and anti-osteoclastogenic properties. Our objective was to investigate the potential of MFG-E8 as a diagnostic or therapeutic agent in periodontitis. MATERIALS AND METHODS:Periodontitis was induced in non-human primates (NHPs) by placing ligatures around posterior teeth on both halves of the mandible for a split-mouth design: one side was treated with MFG-E8-Fc and the other with Fc control. Disease was assessed by clinical periodontal examinations, radiographic analysis of bone loss, and analysis of cytokine mRNA expression in gingival biopsy samples. Gingival crevicular fluid (GCF) was collected from human healthy volunteers or subjects with gingivitis, chronic moderate periodontitis, or chronic severe periodontitis. Additionally, GCF was collected from a subset of severe periodontitispatients following scaling and root planing (SRP) and after pocket reduction surgery. GCF was analysed to quantify MFG-E8 and periodontitis-relevant cytokines using multiplex assays. RESULTS: In NHPs, sites treated with MFG-E8-Fc exhibited significantly less ligature-induced periodontal inflammation and bone loss than Fc control-treated sites. In humans, the GCF levels of MFG-E8 were significantly higher in health than in periodontitis, whereas the reverse was true for the proinflammatory cytokines tested. Consistently, MFG-E8 was elevated in GCF after both non-surgical (SRP) and surgical periodontal treatment of periodontitispatients. CONCLUSION:MFG-E8 is, in principle, a novel therapeutic agent and biomarker of periodontitis.
Authors: Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins Journal: Proc Natl Acad Sci U S A Date: 2013-02-11 Impact factor: 11.205
Authors: Julie Marchesan; Mustafa S Girnary; Li Jing; Michael Zhe Miao; Shaoping Zhang; Lu Sun; Thiago Morelli; Mark H Schoenfisch; Naohiro Inohara; Steven Offenbacher; Yizu Jiao Journal: Nat Protoc Date: 2018-10 Impact factor: 13.491
Authors: Jae Young Lee; Shebli Mehrazarin; Abdullah Alshaikh; Sol Kim; Wei Chen; Renate Lux; Yousang Gwack; Reuben H Kim; Mo K Kang Journal: FASEB J Date: 2019-06-28 Impact factor: 5.191
Authors: Rizky A Irwandi; Scott T Chiesa; George Hajishengallis; Venizelos Papayannopoulos; John E Deanfield; Francesco D'Aiuto Journal: Front Immunol Date: 2022-07-07 Impact factor: 8.786
Authors: Ioannis Kourtzelis; Xiaofei Li; Ioannis Mitroulis; Daniel Grosser; Tetsuhiro Kajikawa; Baomei Wang; Michal Grzybek; Janusz von Renesse; Aleksander Czogalla; Maria Troullinaki; Anaisa Ferreira; Christian Doreth; Klara Ruppova; Lan-Sun Chen; Kavita Hosur; Jong-Hyung Lim; Kyoung-Jin Chung; Sylvia Grossklaus; Anne Kathrin Tausche; Leo A B Joosten; Niki M Moutsopoulos; Ben Wielockx; Antonio Castrillo; Jonathan M Korostoff; Ünal Coskun; George Hajishengallis; Triantafyllos Chavakis Journal: Nat Immunol Date: 2018-11-19 Impact factor: 25.606